Brabant G, Wallaschofski H
Department of Endocrinology, Christie Hospital, Wilmslow Rd, Manchester M20 4BX, UK.
Pituitary. 2007;10(2):129-33. doi: 10.1007/s11102-007-0035-9.
Insulin like growth factor I (IGF-I) represents the key marker for the evaluation of Growth hormone (GH) status. As a large number of determinants including age, gender, genetic factors, nutrition, and disease states influence IGF-I serum levels, accurate normative data are essential to translate patient data into diagnostic meaning or even use IGF-I levels for adequate monitoring of patients with an over- or under-active GH axis. Even though reference ranges have been developed in large cohorts of healthy subjects, the dependency of these data on a given assay technology argues for assay specific normative data for IGF-I.
胰岛素样生长因子I(IGF-I)是评估生长激素(GH)状态的关键标志物。由于包括年龄、性别、遗传因素、营养和疾病状态在内的大量决定因素会影响IGF-I的血清水平,准确的规范数据对于将患者数据转化为诊断意义,甚至用于对生长激素轴活性过高或过低的患者进行充分监测的IGF-I水平而言至关重要。尽管已经在大量健康受试者队列中制定了参考范围,但这些数据对特定检测技术的依赖性表明需要针对IGF-I的特定检测规范数据。